Diversa Technologies

www.diversatechnologies.com ↗ ·Santiago de Compostela ·Seed

Diversa Technologies is a Spanish biotech spin-off (founded January 2022) of the Santiago de Compostela Health Research Institute (IDIS) and the Galician Health Service (SERGAS). It develops a patented lipid-nanosystem platform that carries and protects therapeutic molecules such as mRNA, peptides, proteins and small molecules for drug delivery, selling research/industrial kits (DIVTECH) and licensing its technology; it has been supported by Galician public innovation funds and the EIT Health Bridgehead Programme.

Founded

2022

Founders

Total funds raised

€375K

SectorsBiotechnology, Drug Delivery, Nanomedicine Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Suggest a correction

Founders

Abi Vázquez

Co-founder & COO

María de la Fuente

Co-founder & CEO/CSO

Rafael López

Co-founder & Medical Advisor

Global models 4

ReCode Therapeutics

United States · recodetx.com ↗

Built around a proprietary lipid nanoparticle (SORT LNP) platform for delivering mRNA and other genetic medicines, which it develops in-house and partners out.

$260MComparable

Evox Therapeutics

United Kingdom · www.evoxtherapeutics.com ↗

Drug-delivery platform company using engineered nanovesicles to carry RNA, proteins and other payloads, making money mainly through platform licensing and partnerships.

$230MComparable

Aera Therapeutics

United States · aeratx.com ↗

Delivery-platform biotech whose protein nanoparticles carry nucleic-acid and gene-editing cargo, with the platform itself as the core asset.

$193MComparable

Precision NanoSystems

Canada · www.precisionnanosystems.com ↗

Sold lipid-nanoparticle formulation kits, reagents and instruments to researchers and licensed its LNP know-how, the closest match to Diversa's DIVTECH kits-plus-licensing model (acquired by Cytiva in 2021).

$40MComparable